117 related articles for article (PubMed ID: 25088273)
21. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
22. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
23. Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene.
Plettenberg A; Pammer J; Tschachler E
Exp Dermatol; 1996 Apr; 5(2):102-7. PubMed ID: 8734919
[TBL] [Abstract][Full Text] [Related]
24. Expression of CD40, CD44, bcl-2 antigens and rate of cell proliferation on fine needle aspirates from metastatic melanoma.
Sviatoha V; Rundgren A; Tani E; Hansson J; Kleina R; Skoog L
Cytopathology; 2002 Feb; 13(1):11-21. PubMed ID: 11985564
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma.
Fernández-Figueras MT; Puig L; Musulen E; Gilaberte M; Ferrándiz C; Lerma E; Ariza A
Histopathology; 2005 Jun; 46(6):614-21. PubMed ID: 15910592
[TBL] [Abstract][Full Text] [Related]
26. Tenascin-C in primary Merkel cell carcinoma.
Koljonen V; Jahkola T; Tukiainen E; Granroth G; Haglund C; Böhling T
J Clin Pathol; 2005 Mar; 58(3):297-300. PubMed ID: 15735164
[TBL] [Abstract][Full Text] [Related]
27. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
29. Mast cells have prognostic value in Merkel cell carcinoma.
Beer TW; Ng LB; Murray K
Am J Dermatopathol; 2008 Feb; 30(1):27-30. PubMed ID: 18212540
[TBL] [Abstract][Full Text] [Related]
30. Sentinel-node guided lymph-node dissection for merkel cell carcinoma.
Wasserberg N; Feinmesser M; Schachter J; Fenig E; Gutman H
Eur J Surg Oncol; 1999 Aug; 25(4):444-6. PubMed ID: 10419721
[TBL] [Abstract][Full Text] [Related]
31. Merkel cells and Merkel cell carcinoma express the BCL-2 proto-oncogene.
Plettenberg A; Pammer J; Tschachler E
Exp Dermatol; 1996 Jun; 5(3):183-8. PubMed ID: 8840159
[TBL] [Abstract][Full Text] [Related]
32. Positive sentinel lymph node biopsy predicts local metastases during the course of disease in Merkel cell carcinoma.
Kouzmina M; Leikola J; Böhling T; Koljonen V
J Plast Surg Hand Surg; 2013 Apr; 47(2):139-43. PubMed ID: 23402426
[TBL] [Abstract][Full Text] [Related]
33. Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray.
Knapp CF; Sayegh Z; Schell MJ; Rawal B; Ochoa T; Sondak VK; Messina JL
Am J Dermatopathol; 2012 Aug; 34(6):592-6. PubMed ID: 22814318
[TBL] [Abstract][Full Text] [Related]
34. Merkel cell carcinoma of the eyelid: management and prognosis.
Herbert HM; Sun MT; Selva D; Fernando B; Saleh GM; Beaconsfield M; Collin R; Uddin J; Meligonis G; Leatherbarrow B; Ataullah S; Irion L; McLean CJ; Huilgol SC; Davis G; Sullivan TJ
JAMA Ophthalmol; 2014 Feb; 132(2):197-204. PubMed ID: 24287584
[TBL] [Abstract][Full Text] [Related]
35. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.
Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M
Anticancer Res; 1998; 18(1B):615-8. PubMed ID: 9568186
[TBL] [Abstract][Full Text] [Related]
36. Glucose-6-phosphate dehydrogenase correlates with tumor immune activity and programmed death ligand-1 expression in Merkel cell carcinoma.
Nakamura M; Nagase K; Yoshimitsu M; Magara T; Nojiri Y; Kato H; Kobayashi T; Teramoto Y; Yasuda M; Wada H; Ozawa T; Umemori Y; Ogata D; Morita A
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33361404
[TBL] [Abstract][Full Text] [Related]
37. Merkel cell carcinoma: a clinicopathological study of 11 cases.
Acebo E; Vidaurrazaga N; Varas C; Burgos-Bretones JJ; Díaz-Pérez JL
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):546-51. PubMed ID: 16164706
[TBL] [Abstract][Full Text] [Related]
38. Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumour volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma.
Kitamura S; Yanagi T; Inamura-Takashima Y; Imafuku K; Hata H; Uehara J; Ishida Y; Otsuka A; Hirata K; Shimizu H
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e285-e287. PubMed ID: 29377285
[No Abstract] [Full Text] [Related]
39. Primary neuroendocrine carcinoma of the vagina with Merkel cell carcinoma phenotype.
Coleman NM; Smith-Zagone MJ; Tanyi J; Anderson ML; Coleman RL; Dyson SW; Reed JA
Am J Surg Pathol; 2006 Mar; 30(3):405-10. PubMed ID: 16538063
[TBL] [Abstract][Full Text] [Related]
40. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
